Sponsored by:
The International Parkinson and Movement Disorder Society-European Section (MDS-ES)


Welcome to Venice

This Summit will bring together neurologists, movement disorder specialists, health professionals, residents, students and members of the International Parkinson and Movement Disorder Society.

They will discuss and celebrate therapeutic milestones in the treatment of Parkinson's disease, from Levodopa to surgical and device-aided therapies, into new biological and patient-centered approaches.
 



Dear Colleagues,

I’m happy to invite you to the first Summit on “Therapeutic Milestones in Parkinson’s disease” organized by The International Parkinson and Movement Disorder Society-European Section (MDS-ES).

This is a buzzing time for researchers and people with Parkinson disease. In the last decades we have achieved important milestones in understanding mechanisms of degeneration and contribution of genetics, testing innovative disease modification strategies, developing novel therapeutic targets and medications, optimizing dopaminergic drug delivery and improving neuromodulation techniques.  Finally we have set new standards of care addressing the importance of a multidisciplinary team in disease management and are testing wearable sensors to develop digital endpoints facilitating remote monitoring and drug development.

The Scientific Program of the Summit will address those aspects providing a look into medicine of the future and the need to channel this knowledge into a personalized “patient-centric” approach.

Parkinson's has been the first neurodegenerative disease to see a symptomatic therapy and we hope it will be soon the first to see a cure.

We look forward to welcoming you to Venice in March of 2020 for the first MDS-ES Summit.

Best Regards,

antonini signature

Angelo Antonini

Chair, MDS-ES Summit Oversight Committee



Join us to:

  • Understand the genetic background, the biological mechanisms and the pathology of Parkinson's disease
  • Appraise diagnostic approaches including differential diagnosis with atypical parkinsonism.
  • Evaluate pharmacological and non-pharmacological treatment options available
  • Discuss the role of a multidisciplinary team and the contribution of wearable technology to disease management 

 



Who Should Attend?

Clinicians, researchers, post-doctoral fellows, medical residents, medical students, allied health professionals with an interest in current clinical trends and approaches for diagnosis and treatment of Parkinson disease.

 

 

 

Important Dates

June 24, 2019
Abstract Submission and Travel Grant Applications Open

September 9, 2019
Registration and Housing Open

September 23, 2019
Abstract Submission and Travel Grant Applications Close

March 18-20, 2020
MDS-ES Parkinson’s Disease Summit

For More Information

International Secretariat
555 East Wells Street, Suite 1100
Milwaukee, WI 53202 USA
Phone: +1 414-276-2145
Fax: +1 414-276-3349
Email: essummit@movementdisorders.org
 

Top